Jubilant Pharmova Limited operates as an integrated pharmaceutical company worldwide. It operates through three segments: Pharmaceuticals; Contract Research & Development Services; and Proprietary Novel Drugs. The Pharmaceuticals segment engages in the manufacturing and supply of allergy therapy products, contract manufacturing of sterile injectables and non-sterile products, active pharmaceutical ingredients, and solid dosage formulations, as well as sale of radiopharmaceuticals through a network of 48 radio pharmacies in the United States. The Contract Research & Development Services segment provides collaborative research services to pharmaceutical innovators. The Proprietary Novel Drugs segment develops therapies in the areas of oncology and auto-immune disorders. The company was formerly known as Jubilant Life Sciences Limited and changed its name to Jubilant Pharmova Limited in February 2021. The company was incorporated in 1978 and is headquartered in Noida, India.
Jubilant Pharmova Dividend Announcement
• Jubilant Pharmova announced a annually dividend of ₹5.00 per ordinary share which will be made payable on 2024-09-29. Ex dividend date: 2024-08-02
• Jubilant Pharmova annual dividend for 2024 was ₹5.00
• Jubilant Pharmova annual dividend for 2023 was ₹5.00
• Jubilant Pharmova's trailing twelve-month (TTM) dividend yield is 0.43%
• Jubilant Pharmova's dividend growth over the last five years (2018-2023) was 10.76% year
• Jubilant Pharmova's dividend growth over the last ten years (2013-2023) was 5.24% year
Jubilant Pharmova Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-08-02 | ₹5.00 | annually | 2024-09-29 |
2023-08-10 | ₹5.00 | annually | 2023-09-30 |
2022-08-11 | ₹5.00 | annually | 2022-10-25 |
2021-08-05 | ₹5.00 | annually | 2021-10-20 |
2020-03-09 | ₹5.00 | annually | 2020-03-27 |
2019-09-12 | ₹4.50 | annually | 2019-10-24 |
2018-09-12 | ₹3.00 | annually | 2018-10-25 |
2017-08-16 | ₹3.00 | annually | 2017-09-27 |
2016-08-18 | ₹3.00 | annually | |
2015-08-20 | ₹3.00 | annually | |
2014-08-21 | ₹3.00 | annually | |
2013-08-14 | ₹3.00 | annually |
Jubilant Pharmova Dividend per year
Jubilant Pharmova Dividend growth
Jubilant Pharmova Dividend Yield
Jubilant Pharmova current trailing twelve-month (TTM) dividend yield is 0.43%. Interested in purchasing Jubilant Pharmova stock? Use our calculator to estimate your expected dividend yield:
Jubilant Pharmova Financial Ratios
Jubilant Pharmova Dividend FAQ
Other factors to consider when evaluating Jubilant Pharmova as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Jubilant Pharmova stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Jubilant Pharmova's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Jubilant Pharmova publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Jubilant Pharmova distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Jubilant Pharmova are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Jubilant Pharmova sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Jubilant Pharmova distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Jubilant Pharmova declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Jubilant Pharmova's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Jubilant Pharmova's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.